Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina
- Autores
- Varillas, María Alejandra; Brevedan, Marta Ingrid Victoria; González Vidal, Noelia Luján
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Dissolution studies have evolved from a simple quality control test to an indicator of biopharmaceutical performance and alternative for in vivo equivalence and interchangeability assessment. Pharmaceutical equivalents imply products formulated with the same active pharmaceutical ingredient (API), in the same quantity and dosage form, that are intended to be administered by the same route fulfill the same quality criteria. The medicine market in Argentina is composed mostly of multisource products that are supposed to be pharmaceutical equivalents, but the generic market here is different from other parts of the world. In this scenario, the comparison of different products formulated with the same API becomes essential. Allopurinol, the drug of choice in the treatment of gout and tumor lysis syndrome, is classified as an essential medicine according to the World Health Organization. The present work aimed to compare critical quality attributes and in vitro dissolution characteristics of Allopurinol tablets purchased in Argentina to establish pharmaceutical equivalence. All evaluated products fulfilled the pharmaceutical equivalence criteria. Three of the tested products (the reference and two multisource formulations) comply with the criteria for ‘very rapidly dissolving’ and can be described as similar.
Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina - Materia
-
ALLOPURINOL
BIOPHARMACEUTICAL CLASSIFICATION SYSTEM
DISSOLUTION PROFILE
PHARMACEUTICAL EQUIVALENCE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/129817
Ver los metadatos del registro completo
id |
CONICETDig_06bcab1348cddb63d4cd13b5d665d3ea |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/129817 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in ArgentinaVarillas, María AlejandraBrevedan, Marta Ingrid VictoriaGonzález Vidal, Noelia LujánALLOPURINOLBIOPHARMACEUTICAL CLASSIFICATION SYSTEMDISSOLUTION PROFILEPHARMACEUTICAL EQUIVALENCEhttps://purl.org/becyt/ford/2.11https://purl.org/becyt/ford/2https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3https://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Dissolution studies have evolved from a simple quality control test to an indicator of biopharmaceutical performance and alternative for in vivo equivalence and interchangeability assessment. Pharmaceutical equivalents imply products formulated with the same active pharmaceutical ingredient (API), in the same quantity and dosage form, that are intended to be administered by the same route fulfill the same quality criteria. The medicine market in Argentina is composed mostly of multisource products that are supposed to be pharmaceutical equivalents, but the generic market here is different from other parts of the world. In this scenario, the comparison of different products formulated with the same API becomes essential. Allopurinol, the drug of choice in the treatment of gout and tumor lysis syndrome, is classified as an essential medicine according to the World Health Organization. The present work aimed to compare critical quality attributes and in vitro dissolution characteristics of Allopurinol tablets purchased in Argentina to establish pharmaceutical equivalence. All evaluated products fulfilled the pharmaceutical equivalence criteria. Three of the tested products (the reference and two multisource formulations) comply with the criteria for ‘very rapidly dissolving’ and can be described as similar.Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaDissolution Technologies, Inc2020-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/129817Varillas, María Alejandra; Brevedan, Marta Ingrid Victoria; González Vidal, Noelia Luján; Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 27; 4; 11-2020; 16-231521-298XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/info:eu-repo/semantics/altIdentifier/doi/10.14227/DT270420P15info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:09:08Zoai:ri.conicet.gov.ar:11336/129817instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:09:09.15CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
title |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
spellingShingle |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina Varillas, María Alejandra ALLOPURINOL BIOPHARMACEUTICAL CLASSIFICATION SYSTEM DISSOLUTION PROFILE PHARMACEUTICAL EQUIVALENCE |
title_short |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
title_full |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
title_fullStr |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
title_full_unstemmed |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
title_sort |
Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina |
dc.creator.none.fl_str_mv |
Varillas, María Alejandra Brevedan, Marta Ingrid Victoria González Vidal, Noelia Luján |
author |
Varillas, María Alejandra |
author_facet |
Varillas, María Alejandra Brevedan, Marta Ingrid Victoria González Vidal, Noelia Luján |
author_role |
author |
author2 |
Brevedan, Marta Ingrid Victoria González Vidal, Noelia Luján |
author2_role |
author author |
dc.subject.none.fl_str_mv |
ALLOPURINOL BIOPHARMACEUTICAL CLASSIFICATION SYSTEM DISSOLUTION PROFILE PHARMACEUTICAL EQUIVALENCE |
topic |
ALLOPURINOL BIOPHARMACEUTICAL CLASSIFICATION SYSTEM DISSOLUTION PROFILE PHARMACEUTICAL EQUIVALENCE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.11 https://purl.org/becyt/ford/2 https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Dissolution studies have evolved from a simple quality control test to an indicator of biopharmaceutical performance and alternative for in vivo equivalence and interchangeability assessment. Pharmaceutical equivalents imply products formulated with the same active pharmaceutical ingredient (API), in the same quantity and dosage form, that are intended to be administered by the same route fulfill the same quality criteria. The medicine market in Argentina is composed mostly of multisource products that are supposed to be pharmaceutical equivalents, but the generic market here is different from other parts of the world. In this scenario, the comparison of different products formulated with the same API becomes essential. Allopurinol, the drug of choice in the treatment of gout and tumor lysis syndrome, is classified as an essential medicine according to the World Health Organization. The present work aimed to compare critical quality attributes and in vitro dissolution characteristics of Allopurinol tablets purchased in Argentina to establish pharmaceutical equivalence. All evaluated products fulfilled the pharmaceutical equivalence criteria. Three of the tested products (the reference and two multisource formulations) comply with the criteria for ‘very rapidly dissolving’ and can be described as similar. Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina |
description |
Dissolution studies have evolved from a simple quality control test to an indicator of biopharmaceutical performance and alternative for in vivo equivalence and interchangeability assessment. Pharmaceutical equivalents imply products formulated with the same active pharmaceutical ingredient (API), in the same quantity and dosage form, that are intended to be administered by the same route fulfill the same quality criteria. The medicine market in Argentina is composed mostly of multisource products that are supposed to be pharmaceutical equivalents, but the generic market here is different from other parts of the world. In this scenario, the comparison of different products formulated with the same API becomes essential. Allopurinol, the drug of choice in the treatment of gout and tumor lysis syndrome, is classified as an essential medicine according to the World Health Organization. The present work aimed to compare critical quality attributes and in vitro dissolution characteristics of Allopurinol tablets purchased in Argentina to establish pharmaceutical equivalence. All evaluated products fulfilled the pharmaceutical equivalence criteria. Three of the tested products (the reference and two multisource formulations) comply with the criteria for ‘very rapidly dissolving’ and can be described as similar. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/129817 Varillas, María Alejandra; Brevedan, Marta Ingrid Victoria; González Vidal, Noelia Luján; Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 27; 4; 11-2020; 16-23 1521-298X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/129817 |
identifier_str_mv |
Varillas, María Alejandra; Brevedan, Marta Ingrid Victoria; González Vidal, Noelia Luján; Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 27; 4; 11-2020; 16-23 1521-298X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/ info:eu-repo/semantics/altIdentifier/doi/10.14227/DT270420P15 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270071092674560 |
score |
13.13397 |